227 related articles for article (PubMed ID: 21702039)
21. The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
Liu S; Liu W; Zhao D; Zhang Y; Zhao Z; Luo B
Oncol Res Treat; 2019; 42(11):572-579. PubMed ID: 31522169
[TBL] [Abstract][Full Text] [Related]
22. Association of Epstein Barr virus A73 gene polymorphism with nasopharyngeal carcinoma.
Shen JJ; Niu WN; Zhou M; Zhou F; Zhang HY; Wang L
Genet Test Mol Biomarkers; 2015 Apr; 19(4):187-90. PubMed ID: 25275219
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
25. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients.
Ayadi W; Feki L; Khabir A; Boudawara T; Ghorbel A; Charfeddine I; Daoud J; Frikha M; Hammami A; Karray-Hakim H
Virus Genes; 2007 Apr; 34(2):137-45. PubMed ID: 17216568
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma.
Wong KW; Hui KF; Lam KP; Kwong DL; Lung ML; Yang W; Chiang AKS
PLoS Pathog; 2024 May; 20(5):e1012263. PubMed ID: 38805547
[TBL] [Abstract][Full Text] [Related]
30. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
31. Role of the RARRES1 gene in nasopharyngeal carcinoma.
Kwok WK; Pang JC; Lo KW; Ng HK
Cancer Genet Cytogenet; 2009 Oct; 194(1):58-64. PubMed ID: 19737656
[TBL] [Abstract][Full Text] [Related]
32. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
33. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
34. Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.
Shao N; Wang Y; Lu K; Jiang WY; Li Q; Wang N; Feng NH; Hua LX
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1531-9. PubMed ID: 22526163
[TBL] [Abstract][Full Text] [Related]
35. GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Zhao Y; Guo Y; Wang Z; Xiao Z; Li R; Luo A; Wu C; Jing Z; Sun N; Chen X; Du H; Zeng Y
Oncol Rep; 2015 Sep; 34(3):1369-78. PubMed ID: 26178533
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.
Huang D; Song SJ; Wu ZZ; Wu W; Cui XY; Chen JN; Zeng MS; Su SC
Cancer Res; 2017 Jul; 77(13):3591-3604. PubMed ID: 28484077
[TBL] [Abstract][Full Text] [Related]
37. [Transporter associated with antigen processing 1 637A/G gene polymorphisms and susceptibility to nasopharyngeal carcinoma in Han population in Yunnan Province, China].
Sui J; Mo Q; Li XJ; Ma J; Ren YX; Gao W; Wang H; Yang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):238-43. PubMed ID: 20450707
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
39. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
40. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
